Sort
40,608 grants matching “prostate cancer”
Virginia-UCLA-Toronto Biomarker Characterization Center
$664,127Oliver John Semmes · Eastern Virginia Medical School · U2C · FY2022 · CA
Small Molecule ERG Inhibitors for Prostate Cancer
$664,086John Hackett Bushweller · University Of Virginia · R01 · FY2025 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$663,995Leonard Neckers · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
$663,989Jennifer D Wu · Northwestern University At Chicago · R01 · FY2025 · CA
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
$663,989Jennifer D Wu · Northwestern University At Chicago · R01 · FY2023 · CA
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer
$663,895Kathryn L Penney · Brigham And Women'S Hospital · R37 · FY2019 · CA
Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors
$663,802Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Magneto-Nano Protein Chip and Multiplex Sorter for Monitoring Tumor Markers
$663,785Shan X. Wang · Stanford University · U54 · FY2008 · CA
Software to facilitate multimode, multiscale fused data for Pathology and Radiolo
$663,749Michael D Feldman · University Of Pennsylvania · R01 · FY2010 · CA
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
$663,748Jose M. Garcia · Seattle Inst For Biomedical/Clinical Res · R01 · FY2020 · CA
Multimodal MR-PET Machine Learning Approaches for Primary Prostate Cancer Characterization
$663,746Ciprian Catana · Massachusetts General Hospital · R01 · FY2019 · CA
Development of Protein Degraders Targeting EZH2 Non-enzymatic Functions in Prostate Cancer
$663,713Jindan Yu · Emory University · R01 · FY2024 · CA
Image guided intervention system for pancreatic cystic lesions
$663,707Nicusor Iftimia · Physical Sciences, Inc · R44 · FY2010 · CA
Tulane Medical/Cancer Center Minority-Based Community Clinical Oncology Program
$663,700William Russell Robinson · Tulane University Of Louisiana · U10 · FY2013 · CA
Angiotensin II Receptors And Signaling Mechanisms
$663,660Kevin J Catt · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Metabolic Mechanisms for Programmed Cell Death
$663,560James M Phang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Cell free nucleic acid-based biomarkers in advanced prostate cancer
$663,505Liang Wang · Medical College Of Wisconsin · R01 · FY2017 · CA
Data Processing, Analysis and Modeling Unit
$663,501Jeremy Goecks · Oregon Health & Science University · U2C · FY2021 · CA
Use and Outcomes of Radiation Therapy for Medicare Patients with Common Cancers
$663,470Cary P Gross · Yale University · R01 · FY2010 · CA
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
$663,406Joan M Lappe · Creighton University · R01 · FY2013 · CA
Proactive Outreach and Streamlined Genetic Testing in Prostate Cancer Survivors
$663,383Marc D Schwartz · Georgetown University · R01 · FY2025 · CA
Combining immunotherapy with molecularly targeted radiation therapy
$663,343Lawrence Fong · University Of California, San Francisco · R01 · FY2023 · CA
Platelets in Cancer
$663,334Tatiana V Byzova · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL
Platelets in Cancer
$663,334Tatiana V Byzova · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · HL
Screening for Free: A Value-Based Insurance Design Natural Experiment
$663,309John Hsu · Massachusetts General Hospital · R01 · FY2012 · CA